IMUX
Price
$1.34
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
9 days until earnings call
NTLA
Price
$16.34
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
2 days until earnings call
Ad is loading...

IMUX vs NTLA

Header iconIMUX vs NTLA Comparison
Open Charts IMUX vs NTLABanner chart's image
Immunic
Price$1.34
Change-$0.00 (-0.00%)
Volume$891.41K
CapitalizationN/A
Intellia Therapeutics
Price$16.34
Change-$0.00 (-0.00%)
Volume$3.31M
CapitalizationN/A
View a ticker or compare two or three
IMUX vs NTLA Comparison Chart
Loading...
IMUX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
IMUX vs. NTLA commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMUX is a Buy and NTLA is a Buy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (IMUX: $1.35 vs. NTLA: $16.34)
Brand notoriety: IMUX and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMUX: 116% vs. NTLA: 172%
Market capitalization -- IMUX: $148.63M vs. NTLA: $2.13B
IMUX [@Biotechnology] is valued at $148.63M. NTLA’s [@Biotechnology] market capitalization is $2.13B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMUX’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 0 green FA rating(s).

  • IMUX’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 0 green, 5 red.
According to our system of comparison, IMUX is a better buy in the long-term than NTLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMUX’s TA Score shows that 3 TA indicator(s) are bullish while NTLA’s TA Score has 4 bullish TA indicator(s).

  • IMUX’s TA Score: 3 bullish, 6 bearish.
  • NTLA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than IMUX.

Price Growth

IMUX (@Biotechnology) experienced а -12.90% price change this week, while NTLA (@Biotechnology) price change was -20.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

IMUX is expected to report earnings on Feb 20, 2025.

NTLA is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($2.13B) has a higher market cap than IMUX($149M). IMUX YTD gains are higher at: -10.000 vs. NTLA (-46.409). IMUX has higher annual earnings (EBITDA): -93.53M vs. NTLA (-514.18M). NTLA has more cash in the bank: 691M vs. IMUX (79.7M). IMUX has less debt than NTLA: IMUX (955K) vs NTLA (106M). NTLA has higher revenues than IMUX: NTLA (46M) vs IMUX (0).
IMUXNTLAIMUX / NTLA
Capitalization149M2.13B7%
EBITDA-93.53M-514.18M18%
Gain YTD-10.000-46.40922%
P/E RatioN/AN/A-
Revenue046M-
Total Cash79.7M691M12%
Total Debt955K106M1%
FUNDAMENTALS RATINGS
IMUX vs NTLA: Fundamental Ratings
IMUX
NTLA
OUTLOOK RATING
1..100
36
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
41
Fair valued
PROFIT vs RISK RATING
1..100
10095
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
5591
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMUX's Valuation (34) in the Pharmaceuticals Major industry is in the same range as NTLA (41) in the Biotechnology industry. This means that IMUX’s stock grew similarly to NTLA’s over the last 12 months.

NTLA's Profit vs Risk Rating (95) in the Biotechnology industry is in the same range as IMUX (100) in the Pharmaceuticals Major industry. This means that NTLA’s stock grew similarly to IMUX’s over the last 12 months.

NTLA's SMR Rating (96) in the Biotechnology industry is in the same range as IMUX (98) in the Pharmaceuticals Major industry. This means that NTLA’s stock grew similarly to IMUX’s over the last 12 months.

IMUX's Price Growth Rating (55) in the Pharmaceuticals Major industry is somewhat better than the same rating for NTLA (91) in the Biotechnology industry. This means that IMUX’s stock grew somewhat faster than NTLA’s over the last 12 months.

IMUX's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as NTLA (100) in the Biotechnology industry. This means that IMUX’s stock grew similarly to NTLA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMUXNTLA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 13 days ago
85%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 20 days ago
85%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
IMUX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

IMUX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMUX has been loosely correlated with NTLA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if IMUX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMUX
1D Price
Change %
IMUX100%
-2.88%
NTLA - IMUX
41%
Loosely correlated
+2.45%
RVMD - IMUX
40%
Loosely correlated
+2.87%
DNA - IMUX
40%
Loosely correlated
+1.35%
ALEC - IMUX
39%
Loosely correlated
+6.91%
PGEN - IMUX
38%
Loosely correlated
-0.61%
More

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with BEAM. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
+2.45%
BEAM - NTLA
69%
Closely correlated
+3.71%
VCYT - NTLA
69%
Closely correlated
+3.30%
EDIT - NTLA
67%
Closely correlated
+2.52%
CRSP - NTLA
64%
Loosely correlated
+4.96%
PRME - NTLA
61%
Loosely correlated
+4.47%
More